PTN insider trading
NYSE American HealthcarePALATIN TECHNOLOGIES INC: insider trade history from SEC Form 4 filings.
About PALATIN TECHNOLOGIES INC
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Company website: palatin.com
PTN insider activity at a glance
FilingIQ tracks 353 insider transactions for PTN in filings since Jan 15, 2015. The most recent transaction is dated Jul 15, 2026.
Across the full history, 42 open-market purchases
and 16 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PTN insider trades is 60.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PTN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading PTN
Frequently asked
- How many insider trades does FilingIQ track for PTN?
- FilingIQ tracks 353 Form 4 insider transactions for PTN (PALATIN TECHNOLOGIES INC), covering filings from Jan 15, 2015 onwards. 6 of those are dated within the last 90 days.
- Are PTN insiders net buyers or net sellers?
- Across the full Form 4 history for PTN, 42 transactions (12%) were open-market purchases and 16 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PTN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PTN in?
- PALATIN TECHNOLOGIES INC (PTN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.15M.
Methodology & sources
Every PTN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.